• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Titan Medical finds partner for Sport robotic platform feasibility, validation studies

Titan Medical finds partner for Sport robotic platform feasibility, validation studies

July 10, 2017 By Fink Densford

Titan Medical Sport

Titan Medical (TSX:TMD) said today it inked a collaborative deal with Florida Hospital Nicholson Center to engage in a feasibility and validation study of Titan’s Sport robotic surgical system as the company seeks regulatory approval for the platform.

The Toronto-based robotic surgical system developer said it expects to commence the studies in the 4th quarter, with the studies continuing into 2018.

“We are delighted to enter into this agreement with Florida Hospital Nicholson Center for continued feasibility and validation studies for the Sport system. The Florida Hospital Nicholson Center is a world-class, state-of-the-art training and research facility with demonstrated leadership in robotic surgery innovation and training. With an accessible Orlando location, it has one of the country’s largest and most experienced medical learning and simulation incubation centers dedicated to advancing next-generation clinical knowledge. Through this strategic alliance, Titan will also benefit from access to many leading multispecialty key opinion leaders and their surgical expertise in fine-tuning the Sport system during this critical development phase. Florida Hospital Nicholson Center is one of three sites contemplated for our validation and feasibility studies. We look forward to engaging the other two sites during the current quarter, with completion of these studies in 2018,” Titan Medical rez & CEO David McNally said in a prepared statement.

“We are excited about helping Titan Medical benefit from the clinical expertise our institution offers in further refining their Sport surgical system for regulatory submission. Our brand-new, 54,000-square-foot facility is a model for open collaborations to advance practices and standards across the entire spectrum of minimally invasive, laparoscopic, robotic, telemedicine and medical simulation. It is a place where innovators come together to build upon the brilliant work of industry pioneers to achieve breakthroughs that will revolutionize the way we perform surgery. We believe that Titan’s single port surgical solution holds promise for continuing the surgical revolution,” Florida Hospital Nicholson Center chief medical officer Dr. J. Magnuson said in a press release.

Late last month, Titan Medical said it raised nearly $6 million in a public offering, with company insiders putting up another $166,000.

Filed Under: Business/Financial News, Clinical Trials, Surgical Robotics Tagged With: titanmedical

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy